Altos Labs

Altos Labs is a life sciences company in San Francisco, United States, founded in 2021. It has raised $3.0B across 1 round, most recently a $3.0B Series A in January 2022.

Restoring cell health and resilience

Employees
501–1000
Founded
2021
Business Model
B2B
Total Funding
$3.0B
Last Round
$3.0B Series AJan 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Altos Labs is a biotechnology company pursuing cellular rejuvenation programming to restore cell health and resilience, with the aim of reversing disease, injury, and the disabilities that can occur throughout life. Building on Nobel Prize-winning research in cellular reprogramming, Altos operates research institutes in the San Francisco Bay Area, San Diego, and Cambridge (UK). It launched in 2022 with roughly $3 billion in initial funding from investors including ARCH Venture Partners, Jeff Bezos, and Yuri Milner, making it one of the best-funded biotech startups ever.

Summary

It lists 501–1000 employees. It has raised $3.0B in total across 1 round, most recently a $3.0B Series A round in Jan 2022. Investors include ARCH Venture Partners, Jeff Bezos and Yuri Milner.

Tech & App Stack

17 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJan 2022
$3.0B

Investors

Acquisitions

Similar Companies

BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Altos Labs on Indexed.vc
<a href="https://indexed.vc/companies/altos-labs"><img src="https://indexed.vc/api/badge/company/altos-labs" alt="Altos Labs on Indexed.vc" width="260" height="76" /></a>